-
Publications
-
Multidisciplinary team interpretation performance for indeterminate bone uptake on PSMA PET during prostate cancer staging: Comparison with PROMISE criteria
Priftakis D, Aziz F, Bin Essa N, Davda R, Lyasheva M, Maitra S, Fraioli F, Wan S, Bomanji J, Afaq A European Journal of Nuclear Medicine and Molecular Imaging 2026 May 53 3542-3551 -
18F choline PET/MR to assess clinically significant disease in prostate cancer: correlation with maximum and total cancer core length obtained via template mapping biopsies
Haroon A, Almuhaideb A, Adeleke S, Davis LM, Endozo R, Allie R, Afaq A, Syed GM, Ghafoor S, Emberton M, Bomanji J Nuclear Medicine Communications 2026 -
Clinical Implementation of PSMA-PET Guided Tumor Response-Based Boost Adaptation in Online Adaptive Radiotherapy for High-Risk Prostate Cancer
Li R, Lin MH, Nguyen NC, Su FC, Parsons D, Salcedo E, Phillips E, Domal S, Garant A, Hannan R, Yang D, Afaq A, Lee M, Oz OK, Desai N Cancers 2025 Sep 17 -
Current Applications of PET/MR: Part II: Clinical Applications II
Kohan A, Hanneman K, Mirshahvalad SA, Afaq A, Mallak N, Metser U, Veit-Haibach P Canadian Association of Radiologists Journal 2024 Nov 75 826-837 -
Deep learning applications for quantitative and qualitative PET in PET/MR: technical and clinical unmet needs
Yang J, Afaq A, Sibley R, McMilan A, Pirasteh A Magnetic Resonance Materials in Physics, Biology and Medicine 2024 Aug 37 749-763 -
68Ga-PSMA-Avid Intranasal Solitary Fibrous Tumor
Riaz S, Priftakis D, Afaq A, Kayani I, Bomanji J Clinical nuclear medicine 2023 Apr 48 E184-E185 -
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer
Wang Y, Galante JR, Haroon A, Wan S, Afaq A, Payne H, Bomanji J, Adeleke S, Kasivisvanathan V Nature Reviews Urology 2022 Aug 19 475-493 -
Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy
Author Collaboration F, Payne H, Bomanji J, Bottomley D, Scarsbrook AF, Teoh EJ, Gleeson FV, Bradley KM, Andrade G, Camilieri P, Hyde K, Macpherson R, Patel N, Sabharwal A, Subesinghe M, Chau A, Miller MP, Afaq A, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Han S, Leung HY Nuclear Medicine Communications 2022 Feb 43 201-211 -
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 49, 1, (371-384), 10.1007/s00259-021-05318-y)
Chen SH, Miles K, Taylor SA, Ganeshan B, Rodriquez M, Fraioli F, Wan S, Afaq A, Shortman R, Walls D, Hoy L, Endozo R, Bhargava A, Hanson M, Huang J, Raouf S, Francis D, Siddiqi S, Arulampalam T, Sizer B, Machesney M, Reay-Jones N, Dindyal S, Ng T, Groves AM European Journal of Nuclear Medicine and Molecular Imaging 2022 Jan 49 786-787 -
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis
Chen Sh, Miles K, Taylor SA, Ganeshan B, Rodriquez M, Fraioli F, Wan S, Afaq A, Shortman R, Walls D, Hoy L, Endozo R, Bhargava A, Hanson M, Huang J, Raouf S, Francis D, Siddiqi S, Arulampalam T, Sizer B, Machesney M, Reay-Jones N, Dindyal S, Ng T, Groves AM European Journal of Nuclear Medicine and Molecular Imaging 2021 Dec 49 371-384 -
A Phase II, Open-Label Study to Assess Safety and Management Change Using 68Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study
Afaq A, Payne H, Davda R, Hines J, Cook GJ, Meagher M, Priftakis D, Warbey VS, Kelkar A, Orczyk C, Mitra A, Needleman S, Ferris M, Mullen G, Bomanji J Journal of Nuclear Medicine 2021 Dec 62 1727-1734 -
Pitfalls on PET/MRI
Afaq A, Faul D, Chebrolu VV, Wan S, Hope TA, Haibach PV, Bomanji J Seminars in Nuclear Medicine 2021 Sep 51 529-539 -
Texture analysis of fractional water content images acquired during pet/mri: Initial evidence for an association with total lesion glycolysis, survival and gene mutation profile in primary colorectal cancer
Ganeshan B, Miles K, Afaq A, Punwani S, Rodriguez M, Wan S, Walls D, Hoy L, Khan S, Endozo R, Shortman R, Hoath J, Bhargava A, Hanson M, Francis D, Arulampalam T, Dindyal S, Chen SH, Ng T, Groves A Cancers 2021 Jun 13 -
Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial
Author Collaboration Fs, Scarsbrook AF, Bottomley D, Teoh EJ, Bradley KM, Payne H, Afaq A, Bomanji J, van As N, Chua S, Hoskin P, Chambers A, Cook GJ, Warbey VS, Han S, Leung HY, Chau A, Miller MP, Gleeson FV, Andrade G, Camilieri P, Hyde K, Macpherson R, Patel N, Sabharwal A, Subesinghe M, Tsakok M International Journal of Radiation Oncology Biology Physics 2020 Jun 107 316-324 -
Imaging of Prostate Cancer Recurrence in the Vas Deferens with 68Ga-PSMA PET/CT
Priftakis D, Afaq A, Bomanji J Clinical nuclear medicine 2020 Jan 45 49-51 -
Is it time to fund routine NHS usage of PSMA PET-CT?
Afaq A, Ell PJ, Bomanji JB Nuclear Medicine Communications 2019 Oct 40 975-979 -
Correction to: The clinical utility of prostate cancer heterogeneity using texture analysis of multiparametric MRI (International Urology and Nephrology, (2019), 51, 5, (817-824), 10.1007/s11255-019-02134-0)
Hameed M, Ganeshan B, Shur J, Mukherjee S, Afaq A, Hellawell G, Batura D International Urology and Nephrology 2019 Jul 51 1171 -
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging
Afaq A, Gleeson F, Scarsbrook A, Bradley K, Subesinghe M, MacPherson R, Haroon A, Patel N, Chua S, Wong WL, Vinjamuri S, Warbey VS, Cook GJ, Bomanji J Nuclear Medicine Communications 2019 Jul 40 662-674 -
The clinical utility of prostate cancer heterogeneity using texture analysis of multiparametric MRI
Hameed M, Ganeshan B, Shur J, Mukherjee S, Afaq A, Batura D International Urology and Nephrology 2019 May 51 817-824 -
68 Ga-Prostate-Specific Membrane Antigen PET/CT: Incidental Finding of a Liposarcoma
Militano V, Afaq A, Bomanji J Clinical nuclear medicine 2019 Feb 44 e90-e92 -
Magnetic resonance texture analysis in identifying complete pathological response to neoadjuvant treatment in locally advanced rectal cancer
Aker M, Ganeshan B, Afaq A, Wan S, Groves AM, Arulampalam T Diseases of the Colon and Rectum 2019 Feb 62 163-170 -
Challenges in glucoCEST MR body imaging at 3 Tesla
Kim M, Torrealdea F, Adeleke S, Rega M, Evans V, Beeston T, Soteriou K, Thust S, Kujawa A, Okuchi S, Isaac E, Piga W, Lambert JR, Afaq A, Demetriou E, Choudhary P, Cheung KK, Naik S, Atkinson D, Punwani S, Golay X Quantitative Imaging in Medicine and Surgery 2019 9 1628-1640 -
Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer
Afaq A, Bomanji J British Medical Bulletin 2018 Dec 128 37-48 -
Impact of 68 Ga-prostate-specific membrane antigen PET/CT on prostate cancer management
Afaq A, Alahmed S, Chen SH, Lengana T, Haroon A, Payne H, Ahmed H, Punwani S, Sathekge M, Bomanji J Journal of Nuclear Medicine 2018 Jan 59 89-92 -
Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68 Ga-PSMA, radiolabelled choline and 68 Ga-DOTATATE
Haroon A, Afaq A, Nuthakki S, Freeman A, Biassoni L, Fanti S, Beheshti M, Jan H, Vinjamuri S, Emberton M, Bomanji J Nuclear Medicine Communications 2018 39 196-204 -
New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography
Afaq A, Batura D, Bomanji J International Urology and Nephrology 2017 May 49 803-810 -
Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy
Jalil O, Afaq A, Ganeshan B, Patel UB, Boone D, Endozo R, Groves A, Sizer B, Arulampalam T Colorectal Disease 2017 Apr 19 349-362 -
CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas
Ganeshan B, Miles KA, Babikir S, Shortman R, Afaq A, Ardeshna KM, Groves AM, Kayani I European Radiology 2017 Mar 27 1012-1020 -
Comparison of PET/MRI with PET/CT in the Evaluation of Disease Status in Lymphoma
Afaq A, Fraioli F, Sidhu H, Wan S, Punwani S, Chen SH, Akin O, Linch D, Ardeshna K, Lambert J, Miles K, Groves A, Kayani I Clinical nuclear medicine 2017 Jan 42 e1-e7 -
Volume and landmark analysis: Comparison of MRI measurements obtained with an endorectal coil and with a phased-array coil
Mazaheri Y, Afaq AA, Jung SI, Goldman DA, Wang L, Aslan H, Zelefsky MJ, Akin O, Hricak H Clinical Radiology 2015 Apr 70 379-386 -
PET/MRI in the upper abdomen
Gavra M, Syed R, Fraioli F, Afaq A, Bomanji J Seminars in Nuclear Medicine 2015 45 282-292 -
Assessing therapy response of secreting pineal germ cell tumor on simultaneous 18F-choline PET/MRI
Panagiotidis E, Shankar A, Afaq A, Bomanji J Clinical nuclear medicine 2014 Sep 39 e387-e388 -
Prostate MRI: Evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score
Donati OF, Afaq A, Vargas HA, Mazaheri Y, Zheng J, Moskowitz CS, Hricak H, Akin O Clinical Cancer Research 2014 Jul 20 3705-3711 -
Ultrasound of the gall bladder and biliary tree: Part 1
Wills M, Harvey CJ, Kuzmich S, Afaq A, Cosgrove D British Journal of Hospital Medicine 2014 Jun 75 312-317 -
Ultrasound of the gall bladder and biliary tree: Part 2
Wills M, Harvey CJ, Kuzmich S, Afaq A, Cosgrove D British Journal of Hospital Medicine 2014 Jun 75 318-324 -
Prostate cancer aggressiveness: Assessment with whole-lesion histogram analysis of the apparent diffusion coefficient
Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O RADIOLOGY 2014 Apr 271 143-152 -
Use of PET/MRI for identification and characterisation of liver lesions
Nasoodi A, Syed R, Afaq A, Bomanji J Clinical and Translational Imaging 2014 Apr 2 129-137 -
Characterizing malignant liver lesions with contrast-enhanced ultrasound
Wills M, Harvey CJ, Kuzmich S, Afaq A, Lim A, Cosgrove D British Journal of Hospital Medicine 2014 Mar 75 151-154 -
Characterizing benign liver lesions and trauma with contrast-enhanced ultrasound
Wills M, Harvey CJ, Kuzmich S, Afaq A, Lim A, Cosgrove D British Journal of Hospital Medicine 2014 Feb 75 91-95 -
PET/CT in breast cancer
Afaq A, Sharma B 2014 Jan 142-164 -
Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice
Al-Nabhani KZ, Syed R, Michopoulou S, Alkalbani J, Afaq A, Panagiotidis E, O'Meara C, Groves A, Ell P, Bomanji J Journal of Nuclear Medicine 2014 Jan 55 88-94 -
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients
Win T, Thomas BA, Lambrou T, Hutton BF, Screaton NJ, Porter JC, Maher TM, Endozo R, Shortman RI, Afaq A, Lukey P, Ell PJ, Groves AM European Journal of Nuclear Medicine and Molecular Imaging 2014 41 337-342 -
PET/MRI: A new technology in the field of molecular imaging
Afaq A, Syed R, Bomanji J British Medical Bulletin 2013 Dec 108 159-171 -
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer
Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, Shukla-Dave A, Eastham J, Scardino P, Hricak H Journal of Urology 2012 Nov 188 1732-1738 -
Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy
Riaz N, Afaq A, Akin O, Pei X, Kollmeier MA, Cox B, Hricak H, Zelefsky MJ International Journal of Radiation Oncology Biology Physics 2012 Nov 84 707-711 -
Diffusion-weighted magnetic resonance imaging of the prostate: Improved robustness with stretched exponential modeling
Mazaheri Y, Afaq A, Rowe DB, Lu Y, Shukla-Dave A, Grover J Journal of computer assisted tomography 2012 36 695-703 -
Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer
Afaq A, Koh DM, Padhani A, Van As N, Sohaib SA BJU International 2011 Dec 108 1716-1722 -
Imaging assessment of tumor response: Past, present and future
Afaq A, Akin O Future Oncology 2011 May 7 669-677 -
Diffusion-weighted MRI compared with pet in the detection of metastatic bone disease: A discussion of recent literature
Afaq A, Sharma B Advances in Breast Cancer 2010 Sep 7 19-20 -
Tracheomegaly: A complication of fetal endoscopic tracheal occlusion in the treatment of congenital diaphragmatic hernia
McHugh K, Afaq A, Broderick N, Gabra HO, Roebuck DJ, Elliott MJ Pediatric radiology 2010 May 40 674-680 -
Diffusion-weighted magnetic resonance imaging for tumour response assessment: Why, when and how?
Afaq A, Andreou A, Koh DM Cancer Imaging 2010 10 S179-S188 -
Improving undergraduate education in radiology
Afaq A, McCall J Academic radiology 2002 9 221-223 -
Filmless images for radiology teaching [10]
Afaq A Journal of the Royal Society of Medicine 2001 94 554-555
-
Multidisciplinary team interpretation performance for indeterminate bone uptake on PSMA PET during prostate cancer staging: Comparison with PROMISE criteria
Asim Afaq, M.D.
- Radiology - Abdominal
Education & Training
- Residency - Imperial College Healthcare, NHS Trust (2005-2010), Radiology
- Other - University College of London (2019), Doctor of Philosophy
- Medical Education - Imperial College London, University of London, School of Medicine (1996-2002)
- Fellowship - Memorial Sloan Kettering Cancer Center (2010-2012), Radiology
- Internship - University of London (2002-2005), Internal Medicine & General Surgery
- Fellowship - Royal Marsden Hospital (2009-2010), Radiology